Nutrition, hormones, and breast cancer: Is insulin the missing link?

Cancer Causes and Control

Volumn 7, Issue 6, 1996, Pages 605-625

  Kaaks, Rudolf ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Breast cancer; Insulin; Insulin like growth factors; Nutrition; Obesity; Polycystic ovary syndrome; Puberty; Steroid hormones

Indexed keywords

ANDROGEN; ESTROGEN; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN; STEROID HORMONE;

BREAST CANCER; CANCER RISK; FEMALE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; NUTRITION; OBESITY; OVARY POLYCYSTIC DISEASE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; ADULT; BREAST NEOPLASMS; CHILD; DIETARY CARBOHYDRATES; DIETARY FATS; ENERGY INTAKE; ESTROGENS; FEMALE; HORMONES; HUMANS; HYPERANDROGENISM; HYPERINSULINISM; INCIDENCE; INSULIN; INSULIN RESISTANCE; LIFE STYLE; MENSTRUAL CYCLE; MOTOR ACTIVITY; NUTRITION PHYSIOLOGY; POLYCYSTIC OVARY SYNDROME; POSTMENOPAUSE; PREMENOPAUSE; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 0029970843     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00051703     Document Type: Review

References (355)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594-606.
2. Dunn JE. Breast cancer among American Japanese in the San Francisco Bay area. Natl Cancer Inst Monogr 1977; 47: 157-60.
3. Trichopoulos D, Yen S, Brown J, Cole P, MacMahon B. The effect of Westernization on urine estrogens, frequency of ovulation, and breast cancer risk. (A study of ethnic Chinese in the Orient and the USA.) Cancer 1984; 53: 187-92.
4. Kato I, Tominaga S, Kuroishi T. Relationship between westernization of dietary habits and mortality from breast and ovarian cancers in Japan. Gann 1987; 78: 349-57.
5. Bjarnason O, Day NE, Snaedal G, Tulinius H. The effect of year of birth on the breast cancer age curve in Iceland. Int J Cancer 1974; 13: 689-96.
6. Wakai K, Suzuki S, Ohno Y, Kawamura T, Tamakoshi A, Aoki R. Epidemiology of breast cancer in Japan. Int J Epidemiol 1995; 24: 285-91.
7. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 1975; 15: 617-31.
8. Hems G. The contributions of diet and childbearing to breast-cancer rates. Br J Cancer 1978; 37: 974-82.
9. Eveleth PB, Tanner JM. Worldwide Variation In Human Growth. Cambridge, UK: Cambridge University Press, 1976.
10. Micozzi MS. Nutrition, body size, and breast cancer. Yearbook Phys Anthropol 1985; 28: 175-206.
11. Albanes D, Taylor P. International differences in body height and weight and their relationship to cancer incidence. Nutr Cancer 1990; 14: 69-77.
12. Tarone RE, Chu KC. Implications of birth cohort patterns in interpreting trends in breast cancer rates. JNCI 1992; 84: 1402-10.
13. Frisch RE, Wyshak G, Albright NL, et al. Lower lifetime occurrence of breast cancer and cancers of the reproductive system among former college athletes. Am J Clin Nutr 1987; 45: 328-35.
14. Bernstein L, Henderson BE, Hanish R, Sullivan-Halley J, Ross RK. Physical exercise and reduced breast cancer risk in young women. JNCI 1994; 86: 1403-8.
15. Mittendorf R, Longnecker MP, Newcomer PA, et al. Strenuous physical activity in young adulthood and risk of breast cancer (United States). Cancer Causes Control 1995; 6: 347-53.
16. Welsh CW. Dietary fat, calories, and mammary gland tumorigenesis. In: Jacobs MM, ed. Exercise, Calories, Fat and Cancer. New York, NY (USA): Plenum Press 1992: 203-22.
17. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993; 15: 36-47.
18. Hunter DJ, Willett WC. Diet, body size, and breast cancer. Epidemiol Rev 1993; 15: 110-32.
19. Folsom AR, Kaye SA, Prineas RJ, Potter JD, Gapstur SM, Wallace RB. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol 1990; 131: 794-803.
20. Bruning PF, Bonfrèr JMG, Hart AAM, et al. Body measurements, estrogen availability and the risk of human breast cancer: a case-control study. Int J Cancer 1992; 51: 14-9.
21. Schapira DV, Kumar NB, Lyman GH, Cox CE. Abdominal obesity and breast cancer risk. Ann Intern Med 1990; 112: 182-6.
22. Sellers TA, Kushi LH, Potter JD, et al. Effect of family history, body fat distribution and reproductive factors on the risk of postmenopausal breast cancer. N Engl J Med 1992; 326: 1323-9.
23. den Tonkelaar I, Seidell JC, Collette H. Body fat distribution in relation to breast cancer in women participating in the DOM-project. Breast Cancer Res Treat 1995; 34: 55-61.
24. Ursin G, Longnecker MP, Haile RW, Greenland S. A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology 1995; 6: 137-41.
25. Byers T. Nutritional risk factors for breast cancer. Cancer 1994; 74: 288-95.
26. Howe GR, Hirohata T, Bishop TG, et al. Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. JNCI 1990; 82: 561-9.
27. Boyd NF, Noffel MM, Lockwood GA, Tritchler DL. A meta-analysis of dietary fat and breast cancer risk. Br J Cancer 1993; 68: 627-36.
28. MacKenzie I. The production of mammary cancer in rats using oestrogens. Br J Cancer 1955; 9: 284-99.
29. Staszewski J. Age at menarche and breast cancer. JNCI 1971; 47: 935-40.
30. Trichopoulos D, MacMahon B, Cole P. Menopause and breast cancer risk. JNCI 1972; 48: 605-13.
31. Clemmesen J. Statistical Studies in Malignant Neoplasms. Volume 1. Copenhagen, Denmark: Munksgaard, 1965.
32. Lilienfeld AM. The relationship of cancer of the female breast to artificial menopause and marital status. Cancer 1956; 9: 927-34.
33. Zumoff B. Hormonal profiles in women with breast cancer. Anticancer Res 1988; 8: 627-36.
34. Siiteri PK, Hammond GL, Nisker JA. Increased availability of serum estrogens in breast cancer: a new hypothesis. In: Pike MC, Siiteri PK, Welsch CW, eds. Hormones and Breast Cancer. Cold Spring Harbor, NY (USA): Cold Spring Harbor Laboratory, 1981; Banbury Report No. 8: 87-106.
35. Pardridge WM. Serum availability of sex steroid hormones. Clin Endocrinol Metab 1986; 15: 259-78.
36. Mendel CM. The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev 1989; 10: 232-74.
37. Key TJA, Pike MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988; 24: 29-43.
38. Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 1993; 15: 48-65.
39. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, et al., A prospective study of endogenous estrogens and breast cancer in postmenopausal women. JNCI 1995; 87: 190-7.
40. Dorgan JF, Longcope C, Stephenson HE, et al. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol Biomark Prev 1996; 5: 533-9.
41. Grattarola R. Androgens in breast cancer. I. Atypical endometrial hyperplasia and breast cancer in married premenopausal women. Am J Obstet Gynaecol 1973; 116: 324-8.
42. Grattarola R, Secreto G, Recchione C, Castellini W. Androgens and breast cancer. II. Endometrial adenocarcinoma and breast cancer in married postmenopausal women. Am J Obstet Gynaecol 1974; 118: 173-8.
43. Sommers SC, Theloh HA. Ovarian stromal hyperplasia in breast cancer. Arch Pathol 1952; 53: 160-7.
44. Sommers SC. Endocrine abnormalities in women with breast cancer. Lab Invest 1955; 4: 160-74.
45. Adams J, Poison DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopatic hisutism. Br Med J 1986; 293: 355-9.
46. Conway GS, Honour JW, Jacobs HS. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine, and ultrasound features in 556 patients. Clin Endocrinol 1989; 30: 459-70.
47. Franks S. Polycystic ovary syndrome: a changing perspective. Clinical Endocrinol 1989; 31: 87-120.
48. Secreto G, Fariselli G, Bandieramonte G, Recchione C, Dati V, DiPietro S. Androgen excretion in women with a family history of breast cancer or with epithelial hyperplasia or cancer of the breast. Eur J Cancer Clin Oncol 1983; 19: 5-10.
49. Secreto G, Toniolo P, Berrino F, et al. Increased androgenic activity and breast cancer risk in premenopausal women. Cancer Res 1984; 44: 5902-5.
50. Secreto G, Recchione C, Fariselli G, DiPietro S. High testosterone and low progesterone levels in premenopausal patients with hyperplasia and cancer of the breast. Cancer Res 1984; 44: 841-4.
51. Secreto G, Toniolo P, Pisani P, et al. Androgens and breast cancer in premenopausal women. Cancer Res 1989; 49: 471-6.
52. Secreto G, Recchione C, Cavalleri M, Miraglia M, Dati V. Circulating levels of testosterone, 17ß-oestradiol, luteinizing hormone and prolactin in postmenopausal breast cancer patients. Br J Cancer 1983; 47: 269-75.
53. Secreto G, Toniolo P, Berrino F, et al. Serum and urinary androgens and risk of breast in postmenopausal women. Cancer Res 1991; 51: 2572-6.
54. Malarkey WB, Schroeder LL, Stevens VC, James AG, Lanese RR. Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease. Cancer Res 1977; 37: 4655-9.
55. McFadyen IJ, Forrest APM, Prescott RJ, et al. Circulating hormone levels in women with breast cancer. Lancet 1976; i: 1100-2.
56. Adami HO, Johansson EDB, Vegelius J, Victor A. Serum concentrations of estrone, androstenedione, testosterone and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls. Uppsala J Med Sci 1979; 84: 259-74.
57. Hill P, Garbaczewski L, Kasumi F. Plasma testosterone and breast cancer. Eur J Cancer Clin Oncol 1985; 21: 1256-66.
58. Wysowski DK, Comstock GW, Helsing KJ, Lau HL. Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol 1987; 125: 791-9.
59. Garland CF, Friedlander NJ, Barrett-Connor E, Khaw KT. Sex hormones and postmenopausal breast cancer: a prospective study in an adult community. Am J Epidemiol 1992; 135: 1220-30.
60. Berrino F, Muti P, Micheli A, et al. Serum sex hormone levels after menopause and subsequent breast cancer. JNCI 1996; 88: 291-6.
61. Evans D, Hoffmann RG, Kalkhoff RK, Kissebah AH. Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolite aberrations in premenopausal women. J Clin Endocrinol Metab 1983; 57: 304-10.
62. Seidell JC, Cigolini M, Deurenberg P, Oosterlee A, Doornbos G. Fat distribution, androgens, and metabolism in nonobese women. Am J Clin Nutr 1989; 50: 269-73.
63. Seidell JC, Cigolini M, Charzewska J, et al. Androgenicity in relation to body fat distribution and metabolism in 38-year old women - the European fat distribution study. J Clin Epidemiol 1990; 43: 21-34.
64. Krotkiewski M, Seidell JC, Björntorp P. Glucose tolerance and hyperinsulinemia in obese women: role of adipose tissue distribution, muscle fiber characteristics and androgens. J Intern Med 1990; 228: 385-92.
65. Weaver JU, Holly JMP, Kopelman PG, et al. Decreased sex hormone binding globulin (SHBG) and insulin-like growth factor binding protein (IGFBP-1) in extreme obesity. Clin Endocrinol 1990; 33: 415-22.
66. Kaye SA, Folsom AR, Soler JT, Prineas RJ, Potter JD. Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women. Int J Epidemiol 1991; 20: 151-6.
67. Peiris AN, Sothman MS, Aiman MS, Kissebah AH. The relationship of insulin to sex hormone-binding globulin: role of adiposity. Fertil Steril 1989; 52: 69-72
68. Soler JT, Folsom AR, Kaye SA, Prineas RJ. Associations of abdominal adiposity, fasting insulin, sex hormone binding globulin, and estrone with lipids and lipoproteins in post-menopausal women. Atherosclerosis 1989; 79: 21-7.
69. Haffner SM, Dunn JF, Katz MS. Relationship of sex-hormone-binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women. Metabolism 1992; 41: 278-84.
70. Preziosi P, Barrett-Connor E, Papoz L, et al. Interrelation between plasma sex hormone-binding globulin and plasma insulin in healthy adult women: the Telecom study. J Clin Endocrinol Metab 1993; 76: 283-7.
71. Anderson DC. Sex-hormone-binding globulin. Clin Endocrinol 1974; 3: 69-96.
72. Rosner W The functions of corticosteroid-binding globulin and sex-hormone-binding globulin: recent advances. Endocr Rev 1990; 11: 80-91.
73. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
74. Peiris AN, Sothman MS, Hennes MI, et al. Relative contribution of obesity and body fat distribution to alterations in glucose insulin homeostasis: predictive values of selected indices in premenopausal women. Am J Clin Nutr 1989; 49: 758-64.
75. Kirschner MA, Samojlik E, Drejka M, Szmal E, Schneider G, Ertel N. Androgen-estrogen metabolism in women with upper body versus lower body obesity. J Clin Endocrinol Metab 1990; 70: 473: 9.
76. Kissebah AH, Vydelingum N, Murray, et al. Relation of body fat to metabolic complications of obesity. J Clin Endocrinol Metab 1982; 54: 254-60.
77. Evans DJ, Hoffman RG, Kalkhoff RK, Kissebah AH. Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism 1984; 33: 68-75.
78. Amemiya T, Kawahara R, Yoshino M, Komori K, Hirata Y. Population study on the adipose tissue distribution in Japanese women born in 1948. Diabetes Res Clin Prac 1990; 10: S71-6.
79. Evans DJ, Barth JH, Burke CW. Body fat topography in women with androgen excess. Int J Obes 1988; 12: 157-62.
80. Schriock ED, Buffington CK, Hubert GD, et al. Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding. J Clin Endocrinol Metab 1988; 66: 1329-31.
81. Buffington CK, Givens JR, Kitabchi AE. Opposing actions of dehydroepiandrosterone and testosterone on insulin sensitivity. Diabetes 1991; 40: 693-700.
82. Poretsky L. On the paradox of insulin-induced hyperandrogenism in insulin-resistant states. Endocr Rev 1991; 12: 3-13.
83. Kissebah AH, Peiris A, Evans DJ. Mechanisms associating body fat distribution with the abnormal metabolic profile in obesity. Rec Adv Obes Res 1987; 5: 54-9.
84. Leibel RL, Edens NK, Fried SK. Physiologic basis for the control of body fat distribution in humans. Annu Rev Nutr 1989; 9: 417-43.
85. Bouchard C, Desprès JP, Mauriège P. Genetic and non-genetic determinants of regional fat distribution. Endocr Rev 1993; 14: 72-93.
86. Björntorp P. Insulin resistance and physical exercise in obesity. In: Oomura Y et al, eds. Progress in Obesity Research. Washington, DC: John Libbey & Company 1990: 259-68.
87. Björntorp P. Fatty acids, hyperinsulinaemia, and insulin resistance: which comes first? Curr Opin Lipidol 1994; 5: 166-74.
88. Hernandez ER, Resnick CE, Holtzclaw D, Payne DW, Adashi EY. Insulin as a regulator of androgen biosynthesis by cultured rat ovarian cells: cellular and pharmacological hormonal actions. Endocrinology 1988; 122: 2034-43.
89. Adashi EY, Resnick CE, D'Ercole AJ, Svoboda ME, van Wyk JJ. Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocrinol Rev 1985; 6: 400-20.
90. Poretsky L, Kalin MF. The gonadotropic function of insulin. Endocrinol Rev 1987; 8: 132-41.
91. Nestler JE, Strauss JF. Insulin as an effector of human ovarian and adrenal steroid metabolism. Endocrinol Metab Clin North Am 1991; 20: 807-23.
92. Kiddy DS, Hamilton-Fairley D, Seppälä M, et al. Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin-like growth factor-I. Clin Endocrinol 1989; 31: 757-63.
93. von Schoultz B, Carlström K. On the regulation of sex-hormone-binding globulin - a challenge of an old dogma and outlines of an alternative mechanism. J Steroid Biochem 1989; 2: 327-34.
94. Toscano V, Balducci P, Bianchi P, Mangiantini A, Sciarra F. Steroidal and non-steroidal factors in plasma sex hormone binding globulin regulation. J Steroid Biochem Mol Biol 1992; 43: 431-7.
95. Plymate SR, Matej LA, Jones RE, Friedl KE. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab 1988; 67: 460-4.
96. Plymate SR, Hoop RC, Jones RE, Matej LA. Regulation of sex hormone-binding globulin production by growth factors. Metabolism 1990; 39: 967-70.
97. Singh A, Hamilton-Fairley D, Koistinen R, et al. Effect of insulin-like growth factor-type I (IGF-I) and insulin on the secretion of sex-hormone binding globulin and IGF-I binding protein (IBP-I) by human hepatoma cells. J Endocrinol 1990; 124: R1-3.
98. Holte J, Bergh T, Gennarelli G, Wide L. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Clin Endocrinol 1994; 41: 473-81.
99. Rajkhowa M, Bicknell J, Jones M, Clayton RN. Insulin sensitivity in women with polycystic ovary syndrome: relationship to hyperandrogenemia. Fertil Steril 1994: 61; 605-12.
100. Robinson S, Kiddy D, Gelding SV, et al. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol 1993; 39: 351-5.
101. Franks S, Kiddy DS, Hamilton-Fairley D, Bush A, Sharp PS, Reed MJ. The role of nutrition and insulin in the regulation of sex hormone binding globulin. J Steroid Biochem Mol Biol 1991; 39: 835-8.
102. Sharp PS, Kiddy DS, Reed MJ, Anyaoku V, Johnston DG, Franks S. Correlation of plasma insulin and insulin-like growth factor-I with indices of androgen transport and metabolism in women with polycystic ovary syndrome. Clin Endocrinol 1991; 35: 253-7.
103. Van den Brande JL. Structure of the human insulin-like growth factors: relationship to function. In: Schofield PN. The Insulin-like Growth Factors; Structure and Biological Functions. Oxford, UK: Oxford University Press, 1992: 12-44.
104. Holly JMP, Wass JAH. Insulin-like growth factors: autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developments. J Endocrinol 1989; 122: 611-8.
105. Clemmons DR. Structural and functional analysis of insulin-like growth factors. Br Med Bull 1989; 45: 465-80.
106. Humbel RE. Insulin-like growth factors I and II. Eur J Biochem 1990; 190: 445-62.
107. Bang P, Hall K. Insulin-like growth factors as endocrine and paracrine hormones. In: Schofield PN. The Insulin-like Growth Factors; Structure and Biological Functions. Oxford, UK: Oxford University Press, 1992: 151-77.
108. Moxham C, Jacobs S. Insulin-like growth factor receptors. In: Schofield PN. The Insulin-like Growth Factors; Structure and Biological Functions. Oxford, UK: Oxford University Press, 1992: 80-109.
109. Kahn CR, White MF. The insulin receptor and molecular mechanisms of insulin action. J Clin Invest 1988; 82: 1151-6.
110. D'Ercole AJ, Stiles AD, Underwood LE. Tissue concentrations of somatomedin C: Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci USA 1984; 81: 935-9.
111. Cara JF, Rosenfield RL. Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstirial cells. Endocrinology 1988; 123: 733-9.
112. Baxter RC, Martin JL. Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog Growth Factor Res 1989; 1: 49-68.
113. Clemmons DR, Underwood LE. Nutritional regulation of IGF-I and IGF binding proteins. Annu Rev Nutr 1991; 11: 393-412.
114. Isley WL, Underwood LE, Clemmons DR. Changes in plasma somatomedin-C in response to ingestion of diets with variable protein and energy content. J Parenteral Enteral Nutr 1984; 8: 407-11.
115. Straus DS. Nutritional regulation of hormones and growth factors that control mammalian growth. FASEB J 1994; 8: 6-12.
116. Clemmons DR, Klibanski A, Underwood LE, et al. Reduction of plasma immunoreactive somatomedin C during fasting in humans. J Clin Endocrinol Metab 1981; 53: 1247-50.
117. Minuto F, Barreca A, Adami GF, et al. Insulin-like growth factor-I in human malnutrition: relationship with some body composition and nutritional parameters. J Parenteral Enteral Nutr 1989; 13: 392-6.
118. Smith AT, Clemmons DR, Underwood LE, Ben-Ezra V, McMurray R. The effect of exercise on plasma somatomedin-C/insulin-like growth factor I concentrations. Metabolism 1987; 36: 533-7.
119. Baxter RC, Cowell CT. Diurnal rhythm of the growth hormone-independent binding protein for insulin-like growth factors in human plasma. J Clin Endocrinol Metab 1987; 65: 432-40.
120. Conover CA, Lee PD, Kanaley JA, Clarkson JT, Jensen MD. Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans. J Clin Endocrinol Metab 1992; 74: 1355-60.
121. Holly JM, Biddlecombe RA, Dunger DB, et al. Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin? Clin Endocrinol Oxf 1988; 29: 667-75.
122. Brismar K, Gutniak M, Povoa G, Werner S, Hall K. Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus. J Endocrinol Invest 1988; 11: 599-602.
123. Brismar K, Grill V, Efendic S, Hall K. The insulin-like growth factor binding protein-1 in low and high insulin responders before and during dexamethasone treatment. Metabolism 1991; 40: 728-32.
124. Pekonen F, Laatikainen T, Buyalos R, Rutanen EM. Decreased 34K insulin-like growth factor binding protein in polycystic ovarian disease. Fertil Steril 1989; 51: 972-5.
125. Holly JM, Eden JA, Alaghband-Zadeh J, et al. Insulin-like growth factor binding proteins in follicular fluid from normal dominant and cohort follicles, polcystic and multicystic ovaries. Clin Endocrinol Oxf 1990; 33: 53-64.
126. Suikkari AM, Koivisto VA, Rutanen EM, Yki-Järvinen H, Karonen SL, Seppälä M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor binding protein. J Clin Endocrinol Metab 1988; 66: 266-72.
127. Cotterill AM, Cowell CT, Silink M. Insulin and variation in glucose levels modify the secretion rates of the growth hormone-independent insulin-like growth factor binding protein-1 in the human hepatoblastoma cell line Hep G2. J Endocrinol 1989; 123: R17-20.
128. Conover CA, Lee PD. Insulin regulation of insulin-like growth factor-binding protein production in cultured HepG2 cells. J Clin Endocrmol Metab 1990; 70: 1062-7.
129. Powell DR, Suwanichkul A, Cubbage ML, DePaolis LA, Snuggs MB, Lee PDK. Insulin inhibits transcription of the human gene for insulin-like growth factor-binding protein-1. J Biol Chem 1991; 266: 18868-76.
130. Bar RS, Boes M, Clemmons D, et al. Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF-binding proteins in rat heart. Endocrinology 1990; 127: 497-9.
131. Adashi EY, Resnick CE, Hurwitz A, et al. Insulin-like growth factors: the ovarian connection. Hum Reprod 1991; 6: 1213-9.
132. Koistinen R, Suikkari AM, Tiitinen A, Kontula K, Seppälä M. Human granulosa cells contain insulin-like growth factor binding protein (IGFBP-1) mRNA. Clin Endocrinol Oxf 1990; 32: 635-40.
133. Yen SSC. Chronic anovulation caused by peripheral endocrine disorders. In: Yen SCC, Jaffe RB, eds. Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management. Philadelphia, PA (USA): Saunders Company, 1991: 576-629.
134. Moller DE, Flier JS. Insulin resistance - mechanisms, syndromes, and implications. N Engl J Med 1991; 26: 938-48.
135. Dunaif A. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Medicine 1995; 98(Suppl 1A): 33S-39S.
136. Zavaroni I, Bonara E, Pagliara M, et al. Risk factors for coronary artery disease in healthy persons with hyper-insulinemia and normal glucose tolerance. N Engl J Med 1989; 320: 702-6.
137. Ferranini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-7.
138. Beatty OL, Harper B, Sheridan B, Atkinson AB, Bell PM. Insulin resistance in offspring of hypertensive parents. Br Med J 1993; 307: 92-6.
139. Allemann Y, Horber FF, Colombo M, et al. Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents. Lancet 1993; 341: 327-31.
140. Hollenbeck C, Reaven GM. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 1987; 64: 1169-73.
141. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle, its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; i: 785-9.
142. Clark MG, Rattigan S, Clark DG. Obesity with insulin resistance: experimental results. Lancet 1983; ii: 1236-40.
143. DeFronzo RA. The triumvirate: β-cell, muscle, liver - a collusion responsible for NIDDM. Diabetes 1988; 37: 667-87.
144. O'Dea K. Westernization, insulin resistance and diabetes in Australian Aborigines. Med J Aust 1991: 155: 258-64.
145. Taylor SI, Mukherjee C, Jungas RL. Studies on the mechanism of activation of adipose tissue pyruvate dehydrogenase by insulin. J Biol Chem 1973; 248: 73-81.
146. Taylor SI, Mukherjee C, Jungas RL. Regulation of pyruvate dehydrogenase in isolated rat liver mitochondria. J Biol Chem 1975; 250: 2028-35.
147. Jeanrenaud B, Halimi S, van de Werve G. Neuro-endocrine disorders seen as triggers of the triad: obesity - insulin resistance - abnormal glucose tolerance. Diabetes Metab Rev 1985; 1: 261-92.
148. Wititsuwannakul D, Kim K. Mechanism of palmityl coenzyme A inhibition on liver glycogen synthase. J Biol Chem 1977; 252: 7812-7.
149. Ebeling P, Koivisto VA. Non-esterified fatty acids regulate lipid and glucose oxidation and glycogen synthesis in healthy man. Diabetologia 1994; 37: 202-9.
150. Lillioja S, Mott DM, Zawadzki JK, Young AA, Abbott WG, Bogardus C. Glucose storage is a major determinant of in vivo 'insulin resistance' in subjects with normal glucose tolerance. J Clin Endocrinol Metab 1986; 62: 922-7.
151. 13C nuclear magnetic resonance spectroscopy. N Eng J Med 1990; 322: 223-8.
152. Kraegen EW, Clark PW, Jenkins AB, Dalley EA, Chilholm DJ, Storlien LH. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 1991; 40: 1397-403.
153. Kiens B, Essen-Gustavsson B, Gad P, Lithell H. Lipoprotein lipase activity and intramuscular triglyceride stores after long-term high-fat and high-carbohydrate diets in physically trained men. Clin Physiol 1987; 7: 1-9.
154. Björntorp P. Metabolic abnormalities in visceral obesity. Ann Med 1992; 24: 3-5.
155. Lonnqvist F, Thome A, Nilsell K, Hoffstedt J, Arner P. A pathogenic role of visceral fat beta 3-adrenoreceptors in obesity. J Clin Invest 1995; 95: 1109-16.
156. Mårin P, Andersson B, Ottoson M, et al. The morphology and metabolism of intraabdominal adipose tissue in men. Metabolism 1992; 41: 1242-8.
157. Ferranini E, Barrett EJ, Bevilacqua S. Effect of fatty acids on glucose production and utilization in man. J Clin Invest 1983; 72: 1737-47.
158. Golay A, Swislocki ALM, Chen YDI, Reaven GM. Relationships between plasma free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulm-dependent diabetic individuals. Metabolism 1987; 7: 692-6.
159. Williamson JR, Kreisberg RA, Felts PW. Mechanism for the stimulation of gluconeogenesis in perfused rat liver. Proc Natl Acad Sci USA 1966; 56: 247-54.
160. Williamson JR, Browning ET, Olson M. Interrelations between fatty acid oxidation and the control of gluconeogenesis in perfused rat liver. Adv Enzyme Regul 1968; 6: 67-100.
161. Bar RS, Harrison LC, Muggeo M, Gorden P, Kahn CR, Roth J. Regulation of insulin receptors in normal and abnormal physiology in humans. Adv Intern Med 1972; 24: 23-52.
162. Gavin JR, Roth J, Neville DM, de Meyts P, Buell DN. Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. Proc Natl Acad Sci USA 1974; 7: 84-8.
163. Flier JS. Insulin receptors and insulin resistance. Annu Rev Med 1983; 34: 145-60.
164. Kahn CR. Role of insulin receptors in insulin resistant states. Metabolism 1980; 29: 455-66.
165. Fried SK, Russell CD, Grauso NL, Brolin RE. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest 1993; 92: 2191-8.
166. Ravussin E, Swinburn BA. Pathophysiology of obesity. Lancet 1992; 340: 404-8.
167. Wing RR, Matthews KA, Kuller LH, et al. Environmental and familial contributions to insulin levels and change in insulin levels in middle-aged women. JAMA 1992; 268: 1890-5.
168. Ravussin E, Valencia ME, Esparza J, Bennett PH, Schulz LO. Effects of a traditional lifestyle on obesity in Pima indians. Diabetes Care 1994; 17: 1067-74.
169. Flatt JP. Dietary fat, carbohydrate balance, and weight maintenance. In: Klimeš I, Howard BV, Storlien LH, Sebökovà E, eds. Dietary Lipids and Insulin Action. New York, NY (USA): New York Acad Sci 1993: 122-40.
170. Swinburn B, Ravussin E. Energy balance or fat balance? Am J Clin Nutr 1993; 57(Suppl): 766S-71S.
171. Astrup A, Raben A. Obesity: an inherited metabolic deficiency in the control of macronutrient balance? Eur J Clin Nutr 1992; 46: 611-20.
172. Westerterp KR. Food quotient, respiratory quotient, and energy balance. Am J Clin Nutr 1993; 57(Suppl): 759S-65S.
173. Flatt JP, Ravussin E, Acheson KJ, Jéquier E. Effects of dietary fat on postprandrial substrate oxidation and on carbohydrate and fat balance. J Clin Invest 1985; 76: 1019-24.
174. Schutz Y, Flatt JP, Jéquier E. Failure of fat to promote fat oxidation: a factor favoring the development of obesity. Am J Clin Nutr 1989; 50: 307-14.
175. Eckel RH. Insulin resistance: an adaptation for weight maintenance. Lancet 1992; 340: 1452-3.
176. Astrup A, Buemann B, Western P, Toubro S, Raben A, Christensen NJ. Obesity as an adaptation to a high-fat diet: evidence from a cross-sectional study. Am J Clin Nutr 1994; 59: 350-5.
177. Hales CN, Randle PJ. Effects of low-carbohydrate diet and diabetes mellitus on plasma concentrations of glucose, non-esterified fatty acid, and insulin during oral glucose-tolerance tests. Lancet 1963; i: 790-4.
178. Fukagawa NK, Anderson JW, Hageman G, Young VR, Minaker KL. High-carbohydrate, high-fiber diets increase peripheral insulin sensitivity in healthy young and old adults. Am J Clin Nutr 1990; 52: 524-28.
179. Howard BV, Abbott WGH, Swinburn BA. Evaluation of metabolic effects of substitution of complex carbohydrates for saturated fat in individuals with obesity and NIDDM. Diabetes Care 1991; 14: 786-95.
180. Chen M, Bergman RN, Porte D. Insulin resistance and ß-cell dysfunction in aging: the importance of dietary carbohydrate. J Clin Endocrinol Metab 1988; 67: 951-7.
181. Kolterman OG, Greenfield M, Reaven GM, Saekow M, Olefsky JM. Effect of a high carbohydrate diet on insulin binding to adipocytes and on insulin action in vivo in man. Diabetes 1979; 28: 731-6.
182. Beck-Nielsen H, Pedersen O, Sörensen NS. Effects of diet on the cellular binding and the insulin sensitivity in young healthy subjects. Diabetologia 1978; 15: 289-96.
183. Grey N, Kipnis DM. effect of diet composition on the hyperinsulinemia of obesity. N Engl J Med 1979: 285: 827-31.
184. Coulston AM, Liu GC, Reaven RM. Plasma glucose, insulin and lipid responses to high-carbohydrate low-fat diets in normal humans. Metabolism 1983; 32: 52-6.
185. Danforth E. Diet and obesity. Am J Clin Nutr 1985; 41: 1132-45.
186. Tucker LA, Kano MJ. Dietary fat and body fat: a multivariate study of 205 adult females. Am J Clin Nutr 1992; 56: 616-22.
187. Miller WC, Lindeman AK, Wallace J, Niederpruem M. Diet composition, energy intake, and exercise in relation to body fat in men and women. Am J Clin Nutr 1990; 52: 426-30.
188. Dreon DM, Frey-Hewitt B, Ellsworth N, Williams PT, Terry RB, Wood PD. Dietary fat: carbohydrate ratio and obesity in middle-aged men. Am J Clin Nutr 1988; 47: 995-1000.
189. Romieu I, Willett WC, Stampfer MJ, et al. Energy intake and other determinants of relative weight. Am J Clin Nutr 1988; 47: 406-12.
190. Lilienthal Heitman B, Lissner L, Sörensen TIA, Bengtsson C. Dietary fat and weight gain in women genetically predisposed for obesity. Am J Clin Nutr 1995; 61: 1213-7.
191. Gazzaniga JM, Burns TL. Relationship between diet composition and body fatness, with adjustment for resting energy expenditure and physical activity, in preadolescent children. Am J Clin Nutr 1993; 58: 21-8.
192. Parker DR, Weiss ST, Troisi R, Cassano PA, Vokonas PS, Landsberg L. Relationship of dietary fatty acids and body habitus to serum insulin concentrations: the Normative Aging Study. Am J Clin Nutr 1993; 58: 129-36.
193. Mayer EJ, Newman B, Quesenberry CP, Selby JV. Usual dietary fat intake and insulin concentrations in healthy women twins. Diabetes Care 1991; 16: 1459-69.
194. Maron DJ, Fair JM, Haskell WL, et al. Saturated fat intake and insulin resistance in men with coronary heart disease. Circulation 1991; 84: 2020-7.
195. Lovejoy J, DiGirolamo M. Habitual dietary intake and insulin sensitivity in lean and obese adults. Am J Clin Nutr 1992; 55: 1174-9.
196. Feskens EJM, Kromhout D. Habitual dietary intake and glucose tolerance in euglycaemic men: the Zutphen study. Int J Epidemiol 1990; 19: 953-59.
197. Marshall JA, Hamman RF, Baxter J. High-fat, low-carbohydrate diet and the etiology of non-insulin-dependent diabetes mellitus: the San Luis Valley Diabetes Study. Am J Epidemiol 1991; 134: 590-603.
198. Tsunehara CH, Leonetti DL, Fujimoto WY. Diet of second-generation Japanese-American men with and without non-insulin-dependent diabetes. Am J Clin Nutr 1990; 52: 731-8.
199. Field CJ, Ryan EA, Thompson ABR, Clandinin MT. Diet fat composition alters membrane phospholipid composition, insulin binding, and glucose metabolism in adipocytes from control and diabetic animals. J Biol Chem 1990; 19: 11143-50.
200. Storlien LH, Kraegen EW, Chishol DJ, Ford GL, Bruce DG, Pascoe WS. Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 1987; 237: 885-8.
201. Hainault I, Carlotti M, Hajduch E, Guichard C, Lavau M. Fish oil in a high-lard diet prevents obesity, hyperlipemia, and adiposcyte insulin resistance in rats. Ann NY Acad Sci 1993; 683: 98-101.
202. Pelikanova T, Kohout M, Valek J, Base J, Kazdova L. Insulin secretion and insulin action related to the serum phospholipid fatty acid pattern in healthy men. Metabolism 1989; 38: 188-92.
203. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 1993; 328: 238-44.
204. Ruiz-Gutierrez V, Stifel P, Villar J, Garcia-Donas MA, Acosta D, Carneado J. Cell membrane fatty acid composition type 1 (insulin-dependent) diabetic patients: relationship with sodium transport abnormalities and metabolic control. Diabetologia 1993; 36: 850-6.
205. Agostoni C, Riva E, Bellu R, Vicenzo SS, Grazia BM, Giovannini M. Relationships between the fatty acid status and insulinemic indexes in obese children. Prostaglandins Leukot Essent Fatty Acids 1994; 51: 317-21.
206. Feskens EJM, Loeber JG, Kromhout D. Diet and physical activity as determinants of hyperinsulinaemia: the Zutphen elderly study. Am J Epidemiol 1994; 140: 350-60.
207. Trevisan M, Krogh V, Freudenheim J, et al. Consumption of olive oil, butter, and vegetable oils and coronary heart disease risk factors. JAMA 1990; 263: 688-92.
208. Popp-Snijders C, Schouten JA, Heine RJ, van der Meer J, ven der Veen EA. Dietary supplementation of omega 3 polyunsaturated fatty acids improves insulin sensitivity in non-insulin dependent diabetes. Diabetes Res 1987; 4: 141-7.
209. Schectman G, Kaul S, Kissebah AH. Effect offish oil concentrate on lipoprotein composition in NIDDM. Diabetes 1988; 37: 1567-73.
210. Pilch PF, Thompson PA, Czech MP. Coordinate modulation of D-glucose transport activity and bilayer fluidity in plasma membranes derived from control and insulin-treated adipocytes. Proc Natl Acad Sci USA 1980; 77: 915-8.
211. Ginsberg BH, Jabour J, Spector AA. Increased membrane fluidity is associated with greater sensitivity to insulin (Abstract). Diabetes 1987; 36(Suppl 1): 51A.
212. Truswell AS. Glycaemic index of foods. Eur J Clin Nutr 1992; 46(Suppl 2): S91-101.
213. Jenkins DA, Wolever TMS, Taylor RH, et al. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 1981; 34: 362-6.
214. Collings P, Williams C, Macdonald I. Effects of cooking on serum glucose and insulin responses to starch. Br Med J 1981; 282: 1032-3.
215. Brand JC, Nicholson PL, Thorburn AW, Truswell AS. Food processing and the glycemic index. Am J Clin Nutr 1985; 42: 1192-6.
216. Crapo PA. Simple versus complex carbohydrate use in the diabetic diet. Annu Rev Nutr 1985; 5: 95-114.
217. Wolever TMS. The glycemic index. In: Bourne GH ed. Aspects of Some Vitamins, Minerals and Enzymes in Health and Disease. World Rev Nutr Diet (Basel, Karger) 1990; 62: 120-85.
218. Jenkins DJA, Wolever TMS, Jenkins AL, Lee R, Wong GS, et al. Glycemic response to wheat products: reduced response to pasta but no effects of fiber. Diabetes Care 1983; 6: 155-90.
219. O'Dea K, Nestel PJ, Antonoff L. Physical factors influencing postprandrial glucose and insulin responses to starch. Am J Clin Nutr 1980; 33: 760-5.
220. Jenkins DJA, Wesson V, Wolever TMS, et al. Wholemeal versus wholegrain breads: proportion of whole or cracked grain and the glycaemic response. Br Med J 1988; 297: 958-60.
221. Manolio TA, Savage PJ, Burke GL, et al. Correlates of fasting insulin levels in young adults: the CARDIA study. J Clin Epidemiol 1991; 44: 571-8.
222. Feskens EJ, Kromhout D. Habitual dietary intake and glucose tolerance in euglycemic men: the Zutphen study. Int J Epidemiol 1990; 19: 953-9.
223. Marshall JA, Weiss NS, Hamman RF. The role of dietary fibre in the etiology of non-insulin-dependent diabetes mellitus. Ann Epidemiol 1993; 3: 18-26.
224. Harlan LC, Harlan WR, Landis JR, Goldstein NG. Factors associated with glucose tolerance in US adults. Am J Epidemiol 1987; 126: 674-84.
225. Hill JO, Prentice AM. Sugar and body weight regulation. AmJ Clin Nutr 1995; 62(Suppl): 264S-74S.
226. Koivisto VA, Yki-Jarvinen H, DeFronzo RA. Physical training and insulin sensitivity. Diabetes Metab Rev 1988; 1: 445-81.
227. Regensteiner JG, Mayer EJ, Shetterly SM, et al. Relationship between habitual physical activity and insulin levels among nondiabetic men and women. Diabetes Care 1991; 14: 1066-74.
228. Dowse GK, Zimmet PZ, Gareeboo H, et al. Abdominal obesity and physical inactivity are risk factors for NIDDM and impaired glucose tolerancein Indian, Creole, and Chinese Mauritians. Diabetes Care 1991; 14: 271-82.
229. Lindgarde F, Saltin B, Daily physical activity, work capacity and glucose tolerance in lean and obese normo-glycaemic middle-aged men. Diabetologia 1981; 20: 137-8.
230. Wang JT, Ho LT, Tang KT, Wang LM, Chen YDI, Reaven GM. Effect of habitual physical activity on age-related glucose intolerance. J Am Geriatr Soc 1989; 37: 203-9.
231. Manson JE, Rimm E, Stampfer MJ, et al. Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 1991; 338: 774-8.
232. Holly JMP, Smith CP, Dunger DB, et al. Relationship between the pubertal fall in sex hormone binding globulin and insulin-like growth factor binding protein-I. A synchronized approach to pubertal development? Clin Endocrinol 1989; 31: 277-84.
233. Belgorosky A, Rivarola MA. Progressive increase in nonsex hormone-binding-globulin-bound testosterone and estradiol from infancy to late puberty in girls. J Clin Endocrinol Metab 1988; 67: 234-7.
234. Bartsch W, Horst HJ, Derwahl KM. Interrelations between sex-hormone-binding globulin and 17ß-estradiol, testosterone, 5(-dihydroxytestosterone, thyroxine, and triiodothyronine in prepubertal and pubertal girls. J Clin Endocrinol Metab 1980; 50: 1053-6.
235. Apter D, Vihko R. Endocrine determinants of fertility: serum androgen concentrations during follow-up of adolescents into the third decade of life. J Clin Endocrinol Metab 1984; 71: 970-4.
236. Apter D, Bolton NJ, Hammond GL, Vihko R. Serum sex hormone binding globulin during puberty in girls and in different types of adolescent menstrual cycles. Acta Endocrinologica 1984; 107: 413-9.
237. Lee IR, Lawder LE, Townend DC, Wetherall JD, Hahnel R. Plasma sex hormone binding globulin concentrations and binding capacity in children before and during puberty. Acta Endocrinologica 1985; 109: 276-80.
238. Holly JMP, Smith CP, Dunger DB, et al. Levels of the small insulin-like growth factor-binding protein are strongly related to those of insulin in prepubertal and pubertal children but only weakly so after puberty. J Endocrinol 1989; 121: 383-7.
239. Argente J, Barrios V, Pozo J, et al. Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish pediatric population: age- and sex-related changes. J Clin Endocrinol Metab 1993; 77: 1522-8.
240. Lautala P, Åkerblom HK, Viikari J, et al. Atherosclerosis precursors in Finnish children and adolescents. VII. Serum immunoreactive insulin. Acta Paediatr Scand 1985; 318(Suppl): 127-33.
241. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV. Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 1986; 315: 215-9.
242. Bloch CA, demons P, Sperling MA. Puberty decreases insulin sensitivity. J Pediatr 1987; 110: 481-7.
243. Caprio S, Plewe G, Diamond MD, et al. Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. J Pediatr 1989; 114: 963-7.
244. Smith CP, Archibald HR, Thomas JM, et al. Basal and stimulated insulin levels rise with advancing puberty. Clin Endocrinol 1988; 28: 7-14.
245. Laron Z, Aurbach-Klipper Y, Flasterstein B, Litwin A, Dickerman Z, Heding LG. Changes in endogenous insulin secretion during childhood as expressed by plasma and urinary C-peptide. Clin Endocrinol 1988; 29: 625-32.
246. Travers SH, Jeffers BW, Bloch CA, Hill JO, Eckel RH. Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children. J Clin Endocrinol Metab 1995; 80: 172-8.
247. Clemmons DR, van Wyk JJ. Factors controlling blood concentration of somatomedin C. Clin Endocrinol Metab 1984; 13: 113-43.
248. Smith CP, Dunger DB, Williams AJK, et al. Relationship between insulin, insulin-like growth factor I, and dehydroepiandrosterone sulfate concentrations during childhood, puberty, and adult life. J Clin Endocrinol Metab 1989; 68: 932-7.
249. Hesse V, Jahreis G, Schmabach H, et al. Insulin-like growth factor I correlations to changes of the hormonal status in puberty and age. Exp Clin Endocrinol 1994; 102: 289-8.
250. Wilson DW, Killen JD, Hammer LD, et al. Insulin-like growth factor-I as a reflection of body composition, nutrition, and puberty in sixth and seventh grade girls. J Clin Endocrinol Metab 1991; 73: 907-12.
251. Copeland KC, Colletti RB, Devlin JT, McAuliffe TL. The relationship between insulin-like growth factor I, adiposity, and aging. Metabolism 1990; 39: 584-7.
252. Hindmarsh P, Di Silvio PJ, Pringle PJ, Kurtz AB, Brook CGD. Changes in serum insulin concentration during puberty and their relationship to growth hormone. Clin Endocrinol 1988; 28: 381-8.
253. Arslanian SA, Kalhan SC. Correlations between fatty acid and glucose metabolism: potential explanation of insulin resistance during puberty. Diabetes 1994; 43: 908-14.
254. Benassi L, Tridenri G, Orlandi N, Pezzarossa A. Glucose tolerance and insulin release in adolescent female. J Endocrinol Invest 1991; 14: 751-6.
255. Rosenfeld RG, Wilson DM, Dollar LA, Bennett A, Hintz RL. Both pituitary growth hormone and recombinant DNA-derived growth hormone cause insulin resistance at a postreceptor site. J Clin Endocrinol Metab 1982; 54: 1033-8.
256. Press M, Tamborlane WV, Sherwin RS. Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes. N Engl J Med 1984; 310: 810-5.
257. Rizza RA, Mandarino LJ, Gerich JE. Effects of growth hormone on insulin action in man: Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 1982; 31: 663-9.
258. Martha PM, Reiter EO. Pubertal growth and growth hormone secretion. Endocrinol Metab Clin North Am 1991; 20: 165-82.
259. Bratusch-Marrain PR, Smith D, DeFronzo RA. The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab 1982; 55: 973-82.
260. Zwiauer KF, Pakosta R, Mueller T, Widhalm K. Cardiovascular risk factors in obese children in relation to weight and body fat distribution. J Am Coll Nutr 1992; 11(Suppl): 41S-50S.
261. Kikuchi DA, Srinivasan SR, Harsha DW, Webber LS, Sellers TA, Berenson GS. Relation of serum lipoprotein lipids and apolipoproteins to obesity in children: the Bogalusa Heart Study. Prev Med 1992; 21: 177-90.
262. Hoffman RP, Stumbo PJ, Janz KF, Nielsen DH. Altered insulin resistance is associated with increased dietary weight loss in obese children. Horm Res 1995;44: 17-22.
263. Wabitsch M, Hauner H, Heinze E, et al. Body fat distribution and changes in the atherogenic risk-factor profile in obese adolescent girls during weight reduction. Am J Clin Nutr 1994; 60: 54-60.
264. Arslanian S, Suprasongsin C. Insulin sensitivity, lipids, and body composition in childhood: is 'syndrome X' present? J Clin Endocrinol Metab 1996; 81: 1058-62.
265. Klesges RC, Klesges LM, Eck LH, Shelton ML. A longitudinal analysis of accelerated weight gain in preschool children. Pediatrics 1995; 95: 126-30.
266. Esposito del Puente A, Scalfi L, de Filippo E, et al. Familial and environmental influences on body composition and body fat distribution in childhood in southern Italy. Int J Obes Relat Metab Disord 1994; 18: 596-601.
267. Pasquali R, Casimirri F, Venturoli S, et al. Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome. Metabolism 1994; 43: 706-13.
268. Rebuffe-Scrive M, Cullberg G, Lundberg PA, Lindstedt G, Bjorntorp P. Anthropometric variables and metabolism in polycystic ovarian disease. Horm Metab Res 1989; 21: 391-7.
269. Bringer J, Lefebvre P, Boulet F, et al. Body composition and regional fat distribution in polycystic ovarian syndrome. Relationship to hormonal and metabolic profiles. Ann N Y Acad Sci 1993; 687: 115-23.
270. Lanzone A, Fulghese AM, Pappalardo S, et al. Growth hormone and somatomedin-C secretion in patients with polycystic ovarian disease. Gynecol Obstet Invest 1990; 29: 149-53.
271. Chang RJ, Nakamura RM, Judd HL, Kaplan SO. J Clin Endocrinol Metab 1983; 57: 356-9.
272. Rittmaster RS, Deshwal N, Lehman L. The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome. J Clin Endocrinol Metab 1993; 76: 1295-1300.
273. Conway GS, Jacobs HS, Holly JMP, Wass JAS. Effects of luteinizing hormone, insulin, insulin-like growth factor I and insulin-like growth factor small binding protein in the polycystic ovary syndrome. Clin Endocrinol 1990; 33: 593-603.
274. Tropeano G, Licisano A, Liberale I, et al. Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 1994; 78: 305-9.
275. Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjanski A. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab 1987; 65: 499-507.
276. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989; 38: 1165-74.
277. Suikkari AM, Ruutiainen K, Erkkola R, Seppälä M. Low levels of low molecular weight insulin-like growth factor binding protein in patients with polycystic ovarian disease. Hum Reprod 1989; 4: 136-9.
278. Franks S, Kiddy D, Sharp P, et al. Obesity and polycystic ovary syndrome. Ann NY Acad Sci 1991; 626: 201-6.
279. Kiddy DS, Hamilton-Fairley D, Bush A, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol 1992; 36: 105-11.
280. Venturoli S, Porcu E, Fabbri R, et al. Menstrual irregularities in adolescents: hormonal pattern and ovarian morphology. Hormone Res 1986; 24: 269-79.
281. Poison DW, Wadsworth J, Adams J, Franks S. Polycystic ovaries - a common finding in normal women. Lancet 1988; i: 870-2.
282. Clayton RN, Ogden V, Hodgkinson J, et al. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol 1992; 37: 127-34.
283. Abdel-Gadir A, Khatim MS, Mowafi RS, Alnaser HM, Muharib NS, Shaw RW. Implications of ultrasonically diagnosed polycystic ovaries. I. Correlations with basal hormonal profiles. Hum Reprod 1992; 7: 453-7.
284. Nobels F, Dewailly D. Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor I hypothesis. Fertil Steril 1992; 58: 655-66.
285. Lucky AW, Rosenfield RL, McGuire J, Rudy S, Heike J. Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: Adreanl enzyme defects and exaggerated adrenarche. J Clin Endocrinol Metab 1986; 62: 840-8.
286. Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 1995; 16: 322-53.
287. Pasquali R, Casimirn F. Insulin and androgen relationships with abdominal body fat distribution in women with and without hyperandrogenism. Horm Res 1993; 39: 179-87.
288. Barbieri RL, Smith S, Ryan KJ. The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril 1988; 50: 197-212.
289. Rosenfield RL, Barnes RB, Cara JF, Lucky AW. Dysregulation of cytochrome P450c17( as the cause of polycystic ovarian syndrome. Fertil Steril 1990; 53: 785-91.
290. Magoffin DA, Kurtz KM, Erickson GF. Insulin-like growth factor selectively stimulates cholesterol side-chain cleavage expression in ovarian theca-interstitial cells. Mol Endocrinol 1990; 4: 489-96.
291. Magoffin DA, Weitsman SR. Differentiation of ovarian theca-interstitial cells in vitro: regulation of 17 alpha-hydroxylase messenger ribonucleic acid expression by luteinizing hormone and insulin-like growth factor-I. Endocrinology 1993; 132: 1945-51.
292. Hiney JK, Ojeda SR, Dees WL. Insulin-like growth factor I: a possible metabolic signal involved in the regulation of female puberty. Neuroendocrinology 1991; 54: 420-3.
293. Kazer R. The etiology of polycystic ovary syndrome (PCO). Med Hypotheses 1992; 30: 151-5.
294. Venturoli S, Porcu E, Fabbri R, et al. Postmenarcheal evolution of endocrine pattern and ovarian aspects in adolescents with menstrual irregularities. Fertil Steril 1987; 48: 78-85.
295. Apter D, Vihko R. Endocrine determinants of fertility: serum androgen concentrations during follow-up of adolescents into the third decade of life. J Endocrinol Metab 1990; 71: 970-4.
296. Simpson JL. Elucidating the genetics of polycystic ovary syndrome. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic Ovary Syndrome. Oxford, UK: Blackwell Scientific Publications, 1992: Chapter 6: 59-69.
297. Carey AH, Chan KL, Short F, White D, Williams R, Franks S. Evidence for a single gene effect causing polycystic ovary syndrome and male pattern baldness. Clin Endocrinol 1992; 38: 653-8.
298. Carey AH, Waterworth D, Patel K, et al. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 1994; 3: 1873-6.
299. Dunaif A. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Med 1995; 98: 1A-33S.
300. Prelevic GM, Wurzburger MI, Balint-Peric I, Ginsburg J. Twenry-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries. Horm Res 1992; 37: 125-31.
301. Kazer RR, Unterman TG, Glick RP. An abnormality of the growth hormone/insulin-like growth factor axis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1990; 71: 958-62.
302. Insler V, Shoham Z, Barash A, et al. Polycystic ovaries in non-obese and obese patients: possible pathophysiological mechanism based on new interpretation of facts and findings. Hum Reprod 1993; 8: 379-84.
303. Insler V, Barash A, Shoham Z, et al. Overnight secretion pattern of growth hormone, sex hormone-binding globulin, insulin-like growth factor I, and its binding protein in obese and non-obese women with polycystic ovarian disease. Isr J Med Sci 1994; 30: 42-7.
304. Kopelman PG, White N, Pilkington TR, Jeffcoate SL. The effect of weight loss on sex steroid secretion and binding in massively obese women. Clin Endocrinol Oxf 1981; 15: 113-6.
305. Bates GW, Whitworth NS. Effect of body weight reduction on plasma androgens in obese, infertile women. Fertil Steril 1982; 38: 406-9.
306. Harlass FE, Plymate SR, Fariss BL, Belts RP. Weight loss is associated with correction of gonadotropin and sex steroid abnormalities in the obese anovulatory female. Fertil Steril 1984; 42: 649-52.
307. Crave JC, Fimbel S, Lejeune H, Cugnardey N, Dechaud H, Pugeat M. Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women. J Clin Endocrinol Metab 1995; 80: 2057-62.
308. Wabitsch M, Hauner H, Heinze E, et al. Body fat distribution and steroid hormone concentrations in obese adolescent girls before and after weight reduction. J Clin Endocrinol Metab 1995; 80: 3469-75.
309. Cross M, Dexter TM. Growth factors in development, transformation, and tumorigenesis. Cell 1991; 64: 271-80.
310. Baserga R, Porcu P, Sell C. Oncogenes, growth factors and control of the cell cycle. Cancer Sum 1993; 16: 201-13.
311. King RJB. A discussion of the roles of oestrogen and progestin in human mammary carcinogenesis. J Steroid Biochem Molec Biol 1991; 39: 811-8.
312. Shi YE, Liu YE, Lippman ME, Dickson RB. Progestins and antiprogestins in mammary tumour growth and metastasis. Hum Reprod 1994; 9: 162-73.
313. Henderson BE, Ross R, Bernstein L. Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation Award lecture. Cancer Res 1988; 48: 246-53.
314. Fernig DG, Smith JA, Rudland PS. Relationship of growth factors and differentiation and neoplastic development of the mammary gland. In: Lippman M, Dickson R, eds. Regulatory Mechanisms in Breast Cancer. Boston, MA (USA): Kluwer Publishers, 1991: 47-78
315. Henderson BE, Ross RK, Judd HL, Krailo MD, Pike MC. Do regular ovulatory cycles increase breast cancer risk? Cancer 1985; 56: 1206-8.
316. Spicer DV, Pike MC. The prevention of breast cancer through reduced ovarian steroid exposure. Acta Oncologica 1992; 31: 167-74.
317. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestagens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993; 15: 17-35.
318. Key TJA, Pike MC. The dose-effect relationship between 'unopposed' estrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 1988; 57: 205-12.
319. Macaulay VM. Insulin-like growth factors and cancer. Br J Cancer 1992; 65: 311-20.
320. Yee D, Rosen N, Favoni RE, Cullen KJ. The insulin-like growth factors, their receptors, and their binding proteins in human breast cancer. In: Lippman, Dickson, eds. Regulatory Mechanisms in Breast Cancer. Boston, MA (USA): Kluwer Publishers 1991: 93-105.
321. Hilf R. The actions of insulin as a hormonal factor in breast cancer. In: Pike MC, Siiteri PK, Welsch CW, eds. Hormones and Breast Cancer. Cold Spring Harbor, NY (USA): Cold Spring Harbor Laboratory, 1981; Banbury Report No. 8: 317-37.
322. Stoll BA. Breast cancer: the obesity connection. Br J Cancer 1994; 69: 799-801.
323. Bruning PF, Bonfrèr JMG, van Noord PAH, Hart AAM, de Jong-Bakker M, Nooijen WJ. Insulin resistance and breast cancer risk. Int J Cancer 1992; 52: 511-6.
324. Adami HO, Rimsten A. Prevalence of hypertension and diabetes in breast cancer: a case-control study in 179 patients and age-matched, non-hospitalized controls. Clin Oncol 1978; 4: 243-9.
325. Ragozzino M, Melton LJ, Chu CP, Palumbo PJ. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chron Dis 1982; 35: 13-9.
326. O'Mara BA, Byers T, Schoenfeld E. Diabetes mellitus and cancer risk: a multi-site case-control study. J Chron Dis 1985; 38: 435-41.
327. Franceschi S, la Vecchia C, Negri E, Parazzini F, Boyle P. Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 1990; 26: 781-5.
328. Adami HO, McLaughlin J, Ekbom A, et al. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991; 2: 307-14.
329. Moseson M, Koenig KL, Shore RE, Pasternack BS. The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol 1993; 22: 1000-9.
330. La Vecchia C, Negri E, Franceschi S, D'Avanzo B, Boyle P. A case-control study of diabetes mellitus and cancer risk. Br J Cancer 1994; 70: 950-3.
331. Andersson B, Marin P, Lissner L, Vermeulen A, Bjorntorp P. Testosterone concentrations in women and men with NIDDM. Diabetes Care 1994; 17: 405-11.
332. Nyholm H, Djursing H, Hagen C, Agner T, Bennett P, Svenstrup B. Androgens and estrogens in postmenopausal insulin-treated diabetic women. J Clin Ertdocrinol Metab 1989; 69: 946-9.
333. Djursing H, Hagen C, Nyboe-Andersen A, Sventrup B, Bennet P, Mølsted-Pedersen L. Serum sex hormone concentrations in insulin dependent diabetic women with and without amenorrhea. Clin Endocrinol 1985; 23: 147-54.
334. Prelevic GM, Wurzburger MI, Peric LA. The effect of residual beta-cell activity on menstruation and the reproductive hormone profile of insulin-dependent diabetics. Arch Gynecol Obstet 1989; 244: 207-13.
335. Alexander L, Appleton D, Hall R, Ross WM, Wlikinson R. Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol Oxf 1980; 12: 71-9.
336. Nabarro JDN. Acromegaly. Clin Endocrinol Oxf 1987; 26: 481-512.
337. Bengtsson BÅ, Edén S, Ernest I, Odén A, Sjögren B. Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 1988; 223: 327-35.
338. Ron E, Gridley G, Hrubec Z, Page W, Arora S, Fraumeni JF, Jr. Acromegaly and gastrointestinal cancer. Cancer 1991; 68: 1673-7.
339. Barzilay J, Heatley GJ, Cushing GW. Benign and malignant tumors in patients with acromegaly. Arch Intern Med 1991; 151: 1629-32.
340. Klein I, Parveen G, Gavaler JS, Vanthiel DH. Colonic polyps in patients with acromegaly. Ann Intern Med 1982; 97: 27-30.
341. Ituarte EM, Petrini J, Hershman JM. Acromegaly and colon cancer. Ann Intern Med 1984; 101: 627-8.
342. Pines A, Rozen P, Ron E, Gilat T. Gastrointestinal tumors in acromegalic patients. Am J Gastroenterol 1985; 80: 266-9.
343. Ritter MM, Richter WO, Schwandt P. Acromegaly and colon cancer. Ann Intern Med 1987; 106: 636-7.
344. Ziel FH, Peters AL. Acromegaly and gastrointestinal adenocarcinomas. Ann Intern Med 1988; 109: 514-5.
345. Brunner JE, Johnson CC, Zafar S, Peterson EL, Brunner JF, Mellinger RC. Colon cancer and polyps in acromegaly: increased risk associated with family history of colon cancer. Clin Endocrinol Oxf 1990; 32: 65-71.
346. Ezzat S, Strom C, Melmed S. Colon polyps in acromegaly. Ann Int Med 1991; 114: 754-5.
347. Wynder EL, Hebert JR. Homogeneity and nutritional exposure: an impediment in cancer epidemiology? JNCI 1987; 79: 605-7.
348. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995; 6: 164-79.
349. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomark Prev 1994; 3: 687-95.
350. Siiteri PK, MacDonald PC. The role of extraglandular estrogen in human endocrinology. In: Geiger SR, Astwood EB, Geep RO, eds. Handbook of Physiology. New York, NY (USA): American Physiological Society, 1973: 615-29.
351. Siiteri PK. Obesity and peripheral estrogen synthesis. In: Frisch RE, ed. Adipose Tissue and Reproduction. Basel, Switzerland: Karger 1990; Progr Reprod Biol Med: 14: 70-84.
352. Coulam CB, Annegers JF, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 1983; 61: 403-7.
353. Gammon MD, Thompson WD. Polycystic ovaries and the risk of breast cancer. Am J Epidemiol 1991; 134: 818-24.
354. Ibanez L, Potau N, Virdis R, et al. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1993; 76: 1599-603.
355. Lazar L, Kauli R, Bruchis C, Nordenberg J, Galatzer A, Pertzelan A. Early polycystic ovary-like syndrome in girls with central precocious puberty and exaggerated adrenal response. Eur J Endocrinol 1995; 133: 403-6.